DePuy Synthes Spine receives FDA clearance for thoracic insufficiency syndrome rib devices

DePuy Synthes Spine announced its VEPTR/VEPTR II Vertical Expandable Prosthetic Titanium Rib Devices received 510(k) clearance from the U.S. Food and Drug Administration.

Advertisement

The devices are intended for the treatment of thoracic insufficiency syndrome, a rare congenital condition. The devices were previously available only under Humanitarian Device Exemption regulations. The new 510(k) clearance will improve access to the treatment which has been available since 2004. These devices are the first spine devices to have such a change in regulatory status.

More articles on devices:

Catholic Health purchases spine surgery robotic guidance system: 5 things to know
10 trends in the bone grafts market
Stryker dividend jumps 13%

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.